Cargando…

Interleukin-35 Attenuates D-Galactosamine/Lipopolysaccharide-Induced Liver Injury via Enhancing Interleukin-10 Production in Kupffer Cells

Interleukin (IL) -35 is an anti-inflammatory cytokine which exerts various beneficial effects on autoimmune diseases. However, whether IL-35 plays a role in endotoxin induced hepatitis demands clarification. This study aims to reveal the effect and mechanism of IL-35 on endotoxin induced liver injur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Xing-Feng, Hu, Xiao-Yan, Ma, Bing, Fang, He, Zhang, Fang, Mao, Yan-Fei, Yang, Feng-Yong, Xiao, Shi-Chu, Xia, Zhao-Fan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117388/ https://www.ncbi.nlm.nih.gov/pubmed/30197594 http://dx.doi.org/10.3389/fphar.2018.00959

Ejemplares similares

Deficiency of interleukin-19 exacerbates lipopolysaccharide/D-galactosamine-induced acute liver failure
por: FUJIMOTO, Yasuyuki, et al.
Publicado: (2020)

Protective Effects of Costunolide Against D-Galactosamine and Lipopolysaccharide-Induced Acute Liver Injury in Mice
por: Mao, Jingxin, et al.
Publicado: (2018)

Protective Role of Mytilus edulis Hydrolysate in Lipopolysaccharide-Galactosamine Acute Liver Injury
por: Starikova, Eleonora, et al.
Publicado: (2021)

Pathogenesis and Function of Interleukin-35 in Rheumatoid Arthritis
por: Xin, Pan Lin, et al.
Publicado: (2021)

The Protection of Midazolam Against Immune Mediated Liver Injury Induced by Lipopolysaccharide and Galactosamine in Mice
por: Li, Jian, et al.
Publicado: (2019)

Anxiolytic-like effects of hochuekkito in lipopolysaccharide-treated mice involve interleukin-6 inhibition
por: Ushio, Soichiro, et al.
Publicado: (2022)

Signaling via the Interleukin-10 Receptor Attenuates Cardiac Hypertrophy in Mice During Pressure Overload, but not Isoproterenol Infusion
por: Stafford, Nicholas, et al.
Publicado: (2020)

Mogroside II(E) Inhibits Digestive Enzymes via Suppression of Interleukin 9/Interleukin 9 Receptor Signalling in Acute Pancreatitis
por: Xiao, Juan, et al.
Publicado: (2020)

Effect of T-regulatory cells and interleukin-35, interleukin-10, and transforming growth factor-beta on diffuse large B-cell lymphoma
por: Wu, Hao, et al.
Publicado: (2023)

Interleukin-10 Protection against Lipopolysaccharide-Induced Neuro-Inflammation and Neurotoxicity in Ventral Mesencephalic Cultures
por: Zhu, Yan, et al.
Publicado: (2015)

Intraperitoneal Administration of Fetuin-A Attenuates d-Galactosamine/Lipopolysaccharide-Induced Liver Failure in Mouse
por: Zhang, Pan, et al.
Publicado: (2014)

A novel scoring system for prognostic prediction in d-galactosamine/lipopolysaccharide-induced fulminant hepatic failure BALB/c mice
por: Feng, Bo, et al.
Publicado: (2009)

Adaptive immunoregulation of luteolin and chlorogenic acid in lipopolysaccharide-induced interleukin-10 expression
por: Cheng, Chu-Yen, et al.
Publicado: (2019)

Early-Released Interleukin-10 Significantly Inhibits Lipopolysaccharide-Elicited Neuroinflammation In Vitro
por: Wang, Yubao, et al.
Publicado: (2021)

The Role, Involvement and Function(s) of Interleukin-35 and Interleukin-37 in Disease Pathogenesis
por: Omenesa Bello, Ramatu, et al.
Publicado: (2018)

Interleukin-35 as an Emerging Player in Tumor Microenvironment
por: Xue, Wenhua, et al.
Publicado: (2019)

Nardosinone Suppresses RANKL-Induced Osteoclastogenesis and Attenuates Lipopolysaccharide-Induced Alveolar Bone Resorption
por: Niu, Chenguang, et al.
Publicado: (2017)

Metabonomic analysis of liver tissue from BALB/c mice with d-galactosamine/lipopolysaccharide-induced acute hepatic failure
por: Feng, Bo, et al.
Publicado: (2013)

Overexpression of interleukin-35 associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection
por: Fu, Yi-Peng, et al.
Publicado: (2016)

Interleukin-19 enhances cytokine production induced by lipopolysaccharide and inhibits cytokine production induced by polyI:C in BALB/c mice
por: AZUMA, Yasu-Taka, et al.
Publicado: (2020)

Interleukin 35: protective role and mechanism in type 1 diabetes
por: Zhang, Si-Ming, et al.
Publicado: (2023)

Interleukin 35 regulates interleukin 17 expression and T helper 17 in patients with proliferative diabetic retinopathy
por: Yan, Ai, et al.
Publicado: (2022)

Toddalolactone Protects Lipopolysaccharide-Induced Sepsis and Attenuates Lipopolysaccharide-Induced Inflammatory Response by Modulating HMGB1-NF-κB Translocation
por: Ni, Jingyu, et al.
Publicado: (2020)

Guanabenz Prevents d-Galactosamine/Lipopolysaccharide-Induced Liver Damage and Mortality
por: Perego, Jessica, et al.
Publicado: (2017)

Co-administration of lipopolysaccharide and d-galactosamine induces genotoxicity in mouse liver
por: Dong, Wenjing, et al.
Publicado: (2021)

Levosimendan Increases Survival in a D-Galactosamine and Lipopolysaccharide Rat Model
por: Sakaguchi, Tatsuma, et al.
Publicado: (2022)

Rejuveinix Shows a Favorable Clinical Safety Profile in Human Subjects and Exhibits Potent Preclinical Protective Activity in the Lipopolysaccharide-Galactosamine Mouse Model of Acute Respiratory Distress Syndrome and Multi‐Organ Failure
por: Uckun, Fatih M., et al.
Publicado: (2020)

Effect of Intestinal Microflora on the Production of Interleukin 10 and Prostaglandin E(2) in Serum and Kupffer Cells from Germfree and Conventional Mice
por: Ikeda, Masamichi, et al.
Publicado: (2007)

Interleukin-12 family cytokines and sarcoidosis
por: Ringkowski, Sabine, et al.
Publicado: (2014)

Saccharomyces boulardii Administration Changes Gut Microbiota and Attenuates D-Galactosamine-Induced Liver Injury
por: Yu, Lei, et al.
Publicado: (2017)

Lower serum interleukin‐22 and interleukin‐35 levels are associated with disease status in neuromyelitis optica spectrum disorders
por: Yang, Hong, et al.
Publicado: (2019)

Interleukin-35 is associated with the tumorigenesis and progression of prostate cancer
por: Zhu, Jialin, et al.
Publicado: (2019)

Interleukin-35 promotes Breg expansion and interleukin-10 production in CD19(+) B cells in patients with ankylosing spondylitis
por: Zhang, Yu, et al.
Publicado: (2022)

Interleukin-10 Producing T Lymphocytes Attenuate Dermal Scarring
por: Short, Walker D., et al.
Publicado: (2021)

Interleukin-10 Attenuates Liver Fibrosis Exacerbated by Thermoneutrality
por: Nga, Ha Thi, et al.
Publicado: (2021)

Interleukin-35 expression is associated with colon cancer progression
por: Zhang, Jian, et al.
Publicado: (2017)

Targeting of interleukin-10 receptor by a potential human interleukin-10 peptide efficiently blocks interleukin-10 pathway-dependent cell proliferation
por: Chang, Chun-Chun, et al.
Publicado: (2020)

Mathematical Modeling of Interleukin-35 Promoting Tumor Growth and Angiogenesis
por: Liao, Kang-Ling, et al.
Publicado: (2014)

Sensitive detection of lipopolysaccharides by monitoring of interleukin-10 secretion from human PBMCs
por: Ivanusic, Daniel, et al.
Publicado: (2023)

The Intriguing Role of Interleukin 13 in the Pathophysiology of Asthma
por: Marone, Giancarlo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hi4gfojullcmdqha568i3uf3cl